OPEN END TURBO OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Market Closed - Börse Stuttgart 03:51:04 2024-05-17 pm EDT | ||
| 4.59 EUR | +2.68% |
|
| Current month | -9.82% | ||
| 1 month | -4.97% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 4.59 | +2.68% |
| 24-05-16 | 4.47 | -0.45% |
| 24-05-15 | 4.49 | -7.80% |
| 24-05-14 | 4.87 | -2.79% |
| 24-05-13 | 5.01 | +3.51% |
Delayed Quote Börse Stuttgart
Last update May 17, 2024 at 03:51 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK5CUU |
| ISIN | DE000JK5CUU7 |
| Date issued | 2024-03-11 |
| Strike | 138.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.15 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.09 € |
|---|---|
| Lowest since issue | 4.03 € |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
89.14
USD
Average target price
95.9
USD
Spread / Average Target
+7.59%
- Stock Market
- Certificates
- Certificat
